Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2019 | Factors Associated with Rates of HBsAg Seroclearance in Adults with Chronic HBV Infection: A systematic review and meta-analysis. | Yeo, YH; Ho, HJ; Yang, HI ; Tseng, TC; Hosaka, T; Trinh, HN; Kwak, MS; Park, YM; Fung, JYY; Buti, M; Rodriguez, M; Treeprasertsuk, S; Preda, CM; Ungtrakul, T; Charatcharoenwitthaya, P; Li, X; Li, J; Zhang, J; Le, MH; Wei, B; Zou, B; Le, A; Jeong, D; Chien, N; Kam, L; Lee, CC; Riveiro-Barciela, M; Istratescu, D; Sriprayoon, T; Chong, Y; Tanwandee, T; Kobayashi, M; Suzuki, F; Yuen, MF; Lee, HS; Kao, JH; Lok, AS; Wu, CY; Nguyen, MH | Gastroenterology 156(3), 635-646.e9 | | | |
2020 | Hepatitis B Core-Related Antigen to Indicate High Viral Load: Systematic Review and Meta-Analysis of 10,397 Individual Participants | Yoshida, K; Desbiolles, A; Feldman, SF; Ahn, SH; Alidjinou, EK; Atsukawa, M; Bocket, L; Brunetto, MR; Buti, M; Carey, I; Caviglia, GP; Chen, EQ; Cornberg, M; Enomoto, M; Honda, M; Zu, Siederdissen, CH; Ishigami, M; Janssen, H; Maasoumy, B; Matsui, T; Matsumoto, A; Nishiguchi, S; Riveiro-Barciela, M; Takaki, A; Tangkijvanich, P; Toyoda, H; van Campenhout, MJ; Wang, B; Wei, L; Yang, HI ; Yano, Y; Yatsuhashi, H; Yuen, MF; Tanaka, E; Lemoine, M; Tanaka, Y; Shimakawa, Y | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 19(1), 46-60.e8 | | | |
2022 | Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine | Park, J; Le, AK; Tseng, TC; Yeh, ML; Jun, DW; Trinh, H; Wong, GLH; Chen, CH; Peng, CY; Kim, SE; Oh, H; Kwak, MS; Cheung, KS; Toyoda, H; Hsu, YC; Jeong, JY; Yoon, EL; Ungtrakul, T; Zhang, J; Xie, Q; Ahn, SB; Enomoto, M; Shim, JJ; Cunningham, C; Jeong, SW; Cho, YK; Ogawa, E; Huang, R; Lee, DH; Takahashi, H; Tsai, PC; Huang, CF; Dai, CY; Tseng, CH; Yasuda, S; Kozuka, R; Li, J; Wong, C; Wong, CC; Zhao, C; Hoang, J; Eguchi, Y; Wu, C; Tanaka, Y; Gane, E; Tanwandee, T; Cheung, R; Yuen, MF; Lee, HS; Yu, ML; Kao, JH; Yang, HI ; Nguyen, MH | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20(4), 874-885.e4 | | | |
2020 | Real-world Effectiveness from the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Oral Antiviral Therapy. | Yang, HI ; Yeh, ML; Wong, GL; Peng, CY; Chen, CH; Trinh, HN; Cheung, KS; Xie, Q; Su, TH; Kozuka, R; Lee, DH; Ogawa, E; Zhao, C; Ning, HB; Huang, R; Li, J; Zhang, JQ; Ide, T; Xing, H; Iwane, S; Takahashi, H; Wong, C; Wong, C; Lin, CH; Hoang, J; le, A; Henry, L; Toyoda, H; Ueno, Y; Gane, EJ; Eguchi, Y; Kurosaki, M; Wu, C; Liu, C; Shang, J; Furusyo, N; Enomoto, M; Kao, JH; Yuen, MF; Yu, ML; Nguyen, MH | The Journal of infectious diseases 221(3), 389-399 | | | |
2016 | Real-world risk score for hepatocellular carcinoma (RWS-HCC): a clinically practical risk predictor for HCC in chronic hepatitis B | Poh, Z; Shen, L; Yang, HI ; Seto, WK; Wong, VW; Lin, CY; Goh, BG; Chang, PJ; Chan, HL; Yuen, MF; Chen, CJ ; Tan, CK | GUT 65(5), 887-894 | | | |
2011 | Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score | Yang, HI; Yuen, MF; Chan, HL; Han, KH; Chen, PJ; Kim, DY; Ahn, SH; Chen, CJ; Wong, VW; Seto, WK | Lancet Oncol 12(6), 568-574 | | | |